{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sinusitis/management/chronic-sinusitis/","result":{"pageContext":{"chapter":{"id":"fe33ee40-93d8-59ba-b62a-2f9ccc74cc63","slug":"chronic-sinusitis","fullItemName":"Scenario: Chronic sinusitis","depth":2,"htmlHeader":"<!-- begin field 8be8a524-af6b-44d2-b749-b121e20a8d53 --><h2>Scenario: Chronic sinusitis</h2><!-- end field 8be8a524-af6b-44d2-b749-b121e20a8d53 -->","summary":"Covers the management of people with chronic sinusitis.","htmlStringContent":"<!-- begin item a1726335-d3cb-4c8f-95cb-40696c81c391 --><!-- begin field ab9eeae7-1ecf-47bd-b6f8-acbd0085ce9e --><p>From age 3 months onwards.</p><!-- end field ab9eeae7-1ecf-47bd-b6f8-acbd0085ce9e --><!-- end item a1726335-d3cb-4c8f-95cb-40696c81c391 -->","topic":{"id":"6d2333af-675d-5bf3-8f7d-21404b5f0aa9","topicId":"251eec02-9620-4893-97bb-7a4e69e81da3","topicName":"Sinusitis","slug":"sinusitis","lastRevised":"Last revised in June 2018","chapters":[{"id":"2e4afda1-e9d5-5296-a027-01f4617ab6d0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"405b3d6d-e395-5fea-bc5e-02ddf80a8bd2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"22d307e8-3756-562c-b49a-55d20a9d0c5d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"36290f8d-5730-5655-8fa4-0d3f584a2980","slug":"changes","fullItemName":"Changes"},{"id":"b0ba5cc8-0ed6-52d6-86c5-12833f47d8d3","slug":"update","fullItemName":"Update"}]},{"id":"f730377b-2158-527d-b9a1-e99c0653afd0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5f96218a-0038-5b66-8c21-7db2d19f37b7","slug":"goals","fullItemName":"Goals"},{"id":"f4318fc5-fa1f-52cc-964f-2eeb9d4f7a27","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5a355772-1fc0-5033-929c-388a6956d7f5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41d933ba-5f60-5f51-9a18-8d60f08747d9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"de2c52a0-2248-5977-a8e4-e495835a4f71","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"87fd2967-db43-5938-a83c-4761cd508da1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"6b9273f7-5c2c-5994-a3d4-8617be04677e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"62fda2cc-020c-5dda-8886-be553f1b04bc","slug":"definition","fullItemName":"Definition"},{"id":"d0ca7ab5-8889-52dd-8ac6-bcf949adf403","slug":"causes","fullItemName":"Causes"},{"id":"6c331f3e-5cee-537d-9ff6-41dba5324ae1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2b91bcbf-5ce3-5cdb-bb8d-03f4297a60fc","slug":"complications","fullItemName":"Complications"}]},{"id":"17787dc5-901a-5bd4-93f1-b3bd7830f0a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a3d013cf-b195-59ed-ac16-d0dc956a2637","slug":"diagnosis-acute-sinusitis","fullItemName":"Diagnosis - acute sinusitis"},{"id":"35be5a2e-61f3-5478-b238-c91020678ab0","slug":"diagnosis-chronic-sinusitis","fullItemName":"Diagnosis - chronic sinusitis"},{"id":"3ec7ffd9-5556-5eb7-9e51-14b4e1403c11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a5e0292f-f277-5859-bf17-fe0b4557eae3","fullItemName":"Management","slug":"management","subChapters":[{"id":"851420e1-952f-58e9-bb2d-b69ed5134584","slug":"acute-sinusitis","fullItemName":"Scenario: Acute sinusitis"},{"id":"fe33ee40-93d8-59ba-b62a-2f9ccc74cc63","slug":"chronic-sinusitis","fullItemName":"Scenario: Chronic sinusitis"}]},{"id":"ccbcf182-fe04-59e6-abdc-75557dc3c700","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc9974c3-e759-5746-8c96-b4538af16946","slug":"analgesia","fullItemName":"Analgesia"},{"id":"b7e24d48-87af-5f2c-9097-f4e3b1de894d","slug":"nasal-corticosteroids","fullItemName":"Nasal corticosteroids"},{"id":"5f63c8f8-0eaa-5fe0-b473-2d5e3aef00d1","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"0d802baf-8d25-5d8a-9c6d-b2a448983e4a","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"e874a37b-5cc8-58c8-9335-ac01e3b17271","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"bb4fef09-b30c-5637-ae85-ba203f26acd9","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"827f1e92-8727-5460-b9ae-00929701cc77","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dbc93c2-6562-533b-8dd9-0891fc35822e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8b0f7242-5fbb-5eb4-8b1a-13af5d4383df","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4a3d9d72-ed21-52d6-ba45-abcfb27ec6b4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1b69a1e4-ec7f-5483-873c-2bb4bfb1345c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f04034ff-dd83-5bf5-83de-77fe9877df85","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f54f59b3-2893-5e4b-8dd2-3bee521cb237","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"164a0943-7f01-50bd-8c8f-a3695b72b662","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a5e0292f-f277-5859-bf17-fe0b4557eae3","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"d39eb424-ee3d-5915-bc86-73902fc9ad6e","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field ae6260ce-8128-41f3-b3f0-7ed615d7ae93 --><h3>How should I manage a person with chronic sinusitis?</h3><!-- end field ae6260ce-8128-41f3-b3f0-7ed615d7ae93 -->","summary":null,"htmlStringContent":"<!-- begin item 26290890-bf83-4132-9d84-853b3bc9f791 --><!-- begin field 395e4e05-272f-4ff9-a250-78e901948bbd --><ul><li><strong>Arrange admission if sinusitis is associated with a severe systemic infection, or a serious complication </strong><strong>including:</strong><ul><li>Orbital involvement — indicated by peri-orbital oedema or cellulitis, a displaced globe, double vision, ophthalmoplegia, or reduced visual acuity.</li><li>Intracranial involvement — indicated by severe frontal headache, swelling over the frontal bone, symptoms or signs of meningitis, or focal neurological signs.</li></ul></li><li><strong>Inform the person that chronic sinusitis may last several months.</strong> If they have an associated disorder, such as <a class=\"topic-reference external-reference\" href=\"/topics/allergic-rhinitis/\">allergic rhinitis</a> or <a class=\"topic-reference external-reference\" href=\"/topics/asthma/\">asthma</a>, advise them that good control of these is also likely to benefit their sinusitis symptoms.<ul><li>Offer written advice, such as the ENT UK publication <a href=\"https://www.entuk.org/sites/default/files/files/ENT/Sinusitis%206pp%20DL%20(09006)_7_16.pdf\" data-hyperlink-id=\"165b92dc-1eb1-434e-94ac-a8fd00f3f4e7\">About sinusitis</a> or NHS information on <a href=\"https://www.nhs.uk/conditions/sinusitis-sinus-infection/\" data-hyperlink-id=\"457d16e4-ec32-4a0e-a264-aa6b0174bcba\">Sinusitis (sinus infection)</a>.</li></ul></li><li><strong>Advise the person to:</strong><ul><li>Avoid allergic triggers.</li><li>Stop smoking (and avoid passive smoking), where applicable.</li><li>Practise good dental hygiene to reduce the risk of dental infection (which can be associated with chronic sinusitis).</li><li>Avoid underwater diving if there are prominent symptoms.</li></ul></li><li><strong>Consider nasal irrigation with saline solution </strong>to relieve congestion and nasal discharge. <ul><li>The NHS information on <a href=\"https://www.nhs.uk/conditions/sinusitis-sinus-infection/\" data-hyperlink-id=\"51cbe3d3-c293-4194-b571-a8fd00f3f523\">Sinusitis (sinus infection)</a> contains instructions on cleaning the nose with a salt water solution.</li></ul></li><li><strong>Consider a course of intranasal corticosteroids </strong>(for example, mometasone or fluticasone) for up to 3 months, especially if there is suspicion of an allergic cause (such as concomitant allergic rhinitis). If intranasal corticosteroids are being considered for a child, seek specialist advice.<ul><li>For more information on the use of intranasal corticosteroids in allergic rhinitis, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/allergic-rhinitis/\">Allergic rhinitis</a>. <strong> </strong></li></ul></li><li><strong>Seek specialist advice before prescribing long-term antibiotics, </strong>as the evidence for this approach is limited.</li><li><strong>If the person suffers from recurrent acute episodes, see the </strong><a class=\"topic-reference internal-reference\" href=\"/topics/sinusitis/management/acute-sinusitis/\">Scenario: Acute sinusitis</a>.</li><li><strong>Consider referral to an appropriate specialist</strong> (for example, ear, nose, and throat specialist or immunologist) if there are:<ul><li>Unilateral symptoms (consider urgent referral as this increases suspicion of neoplasia).</li><li>Persistent symptoms despite compliance with 3 months of treatment.</li><li>Nasal polyps complicating assessment or treatment, particularly if present in children. </li><li>Recurrent episodes of otitis media and pneumonia in a child.</li><li>Unusual opportunistic infections. </li><li>Symptoms that significantly interfere with functioning and quality of life.<strong> </strong></li><li>Allergic or immunologic risk factors that need investigating.<strong> </strong></li></ul></li></ul><!-- end field 395e4e05-272f-4ff9-a250-78e901948bbd --><!-- end item 26290890-bf83-4132-9d84-853b3bc9f791 -->","subChapters":[{"id":"0a101fad-e776-54ed-a61a-6001cb907cc5","slug":"basis-for-recommendation-b28","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a9c6e20f-fc46-49cd-b4bb-fbfef7bd90ff --><h4>Basis for recommendation</h4><!-- end field a9c6e20f-fc46-49cd-b4bb-fbfef7bd90ff -->","summary":null,"htmlStringContent":"<!-- begin item b28d45fc-c75f-4c0d-a206-c1e67f597ba6 --><!-- begin field 0feb286f-00d9-4086-b6a3-195825956f68 --><h5>Arranging admission</h5><ul><li>This recommendation is extrapolated from the National Institute for Health and Care Excellence guideline <em>Sinusitis (acute): antimicrobial prescribing</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">NICE, 2017</a>] because orbital and intracranial complications and bacterial infection can also be associated with chronic sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Sedaghat, 2017</a>].  </li></ul><h5>Giving information about prognosis</h5><ul><li>The natural course of chronic sinusitis is poorly documented, but persistent symptoms are likely to last months or longer without appropriate management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Blomgren et al, 2005</a>]. </li><li>A summary of Canadian guidelines for chronic sinusitis advises identifying and addressing contributing factors (for example, asthma, allergic rhinitis, immune dysfunction) and avoiding allergic triggers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>].  </li></ul><h5>Offering written advice</h5><ul><li>This recommendation is based on expert opinion in a UK commissioning guide that discusses the importance of active patient involvement in treatment decisions and informed choice [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>].  </li></ul><h5>Giving advice on avoiding triggers</h5><ul><li>A summary of a Canadian guideline on chronic sinusitis advises avoidance of allergic triggers and smoking [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>]. Although there is no strong evidence that smoking causes chronic sinusitis, there is a hypothetical risk that tobacco smoke may exacerbate chronic sinusitis symptoms, particularly in people with allergies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Benninger, 1999</a>].</li><li>Dental infection can be associated with chronic sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Fokkens et al, 2012</a>], so dental hygiene should be encouraged.</li><li>Underwater diving is not recommended because there is a risk of sinus barotrauma (tissue injury resulting from pressure differences). Potential complications of barotrauma include cerebral empyema, pneumocephalus, blindness, and cranial nerve palsies [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Parell and Becker, 2000</a>].</li></ul><h5>Nasal irrigation</h5><ul><li>Irrigation of the nose with saline solution is recommended based on expert opinion in the <em>European </em><em>Position Paper on Rhinosinusitis and Nasal Polyps 2012 </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Fokkens et al, 2012</a>], a UK commissioning guide [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>], and international guidelines and expert consensus statements on sinusitis in adults and children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Brietzke et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Peters et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Rosenfeld et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Orlandi et al, 2016</a>]. </li><li>Evidence to support the use of saline irrigation is weak:<ul><li>A Cochrane systematic review (search date October 2015) studied the effects of saline irrigation in people with chronic sinusitis. Two RCTs which differed in terms of population, intervention and comparisons, were identified: one was placebo-controlled, included people with and without polyps, and used large-volume hypertonic saline irrigation (n = 76). The other compared nebulised saline twice daily with intranasal corticosteroids in people with nasal polyps (n = 40) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Chong et al, 2016a</a>]. <ul><li>Saline irrigation with large volume hypertonic nasal saline showed an improvement in disease-specific health-related quality of life compared with placebo after 3 months of treatment (low-quality evidence), an effect which was more marked at 6 months (very low-quality evidence).</li><li>The people with intranasal corticosteroids reported less severe symptoms than the nebulised saline group in terms of disease-specific health-related quality of life (very low-quality evidence).</li></ul></li><li>A previous Cochrane systematic review of saline nasal irrigation for acute upper respiratory tract infections was also unable to draw definite conclusions due to the limitations of the evidence [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">King et al, 2015</a>].  </li><li>Two systematic reviews found no studies specifically looking at the use of nasal saline irrigation in children with chronic sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Shaikh and Wald, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Gallant et al, 2018</a>].</li></ul></li></ul><h5>Prescribing intranasal corticosteroids for chronic sinusitis</h5><ul><li>Intranasal corticosteroids are recommended for the treatment of chronic sinusitis both with and without nasal polyps in the <em>European </em><em>Position Paper on Rhinosinusitis and Nasal Polyps 2012 </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Fokkens et al, 2012</a>], a UK commissioning guide [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>], and international guidelines and expert consensus statements covering the management of adults and children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Brietzke et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Peters et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Rosenfeld et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Orlandi et al, 2016</a>].<ul><li>For adults, the choice of corticosteroid is based on expert opinion in a primary care pathway published by ENT UK and the Royal College of Surgeons, and the duration of treatment is extrapolated from evidence that non-responders to treatment are unlikely to experience improvement, and may worsen after 3 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>]. <strong> </strong></li><li>CKS recommends seeking specialist advice if considering intranasal corticosteroid treatment for a child with chronic sinusitis because of the lack of evidence regarding type of corticosteroid, dose, and duration of treatment when managing this group in primary care.</li></ul></li><li>A Cochrane systematic review (search date August 2015) compared the use of intranasal steroids, using a variety of methods of administration, with placebo in people with chronic sinusitis. Eighteen RCTs (n = 2738) were identified, of which the majority (14 studies) included people with nasal polyps. In terms of disease severity, improvement with nasal corticosteroids was reported for all symptoms, nasal blockage (moderate benefit) and rhinorrhoea (small benefit), although the quality of the evidence was low or medium. The evidence on quality of life was of very low quality and showed no significant difference between the intranasal corticosteroid and placebo groups [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Chong et al, 2016b</a>].</li><li>A Cochrane systematic review (search date August 2015) studied different types of intranasal steroids for chronic sinusitis. Nine RCTs including 911 participants found insufficient evidence to support recommendations on the use of one type of intranasal steroid over another; use of aerosol or spray; or use of higher compared with lower doses in people with chronic sinusitis. The Cochrane authors identified a need for further research [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Chong et al, 2016c</a>].</li></ul><h5>Antibiotics</h5><ul><li>Experts discourage the use of long-term antibiotics for chronic sinusitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Orlandi et al, 2016</a>], but acknowledge there may be a place for their use for acute exacerbations in a person with chronic sinusitis (for example, purulent discharge, pain) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Peters et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Sedaghat, 2017</a>]. It is not certain what the optimal drug or dosage is, and which specific groups of people are most likely to benefit [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Orlandi et al, 2016</a>]. </li><li>CKS recommends seeking specialist advice before long-term antibiotics are initiated because of the potential for adverse effects, the concern of increasing bacterial resistance, the low specificity of a symptomatic primary care diagnosis, and the lack of evidence of efficacy other than in selected groups [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>].<ul><li>A Cochrane systematic review (search date September 2015) investigated the effects of systemic antibiotics for chronic rhinosinusitis. Five RCTs were identified, but there were differences between the studies: four included adults, and one children; three included people with nasal polyps, one without nasal polyps, and one with either. There was only a small amount of evidence that systemic antibiotics are effective in people with chronic sinusitis and the Cochrane authors concluded that more research is needed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Head et al, 2016</a>].  <ul><li>Of the three studies comparing antibiotics with placebo, after 3 months of treatment, one (n = 64) found a better disease-specific health-related quality of life in the antibiotic (macrolide) group compared with placebo in people without polyps, although the quality of the evidence was moderate. It is not certain if these results persisted 3 months later.</li></ul></li></ul></li></ul><h5>Referral</h5><ul><li>Referral recommendations are based on expert opinion and are consistent with a UK commissioning guide [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>], Canadian and US consensus guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Peters et al, 2014</a>],<strong> </strong>and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Sedaghat, 2017</a>]. <ul><li>Routine referral is recommended if a trial of intranasal corticosteroids has not proved adequately effective because other diagnoses should be considered if the person fails to respond to treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>].  </li><li>Investigations and treatments that may be offered in secondary care include [<a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Kaplan, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Brietzke et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Peters et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Rosenfeld et al, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">ENT UK and Royal College of Surgeons, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">Sedaghat, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sinusitis/references/\">BMJ Best Practice, 2017</a>]: <ul><li>Diagnostic nasal endoscopy to document signs of inflammation and the presence of polyps. </li><li>Further investigation such as CT imaging to rule out complications or neoplasia and to confirm the diagnosis.</li><li>Allergy testing — allergy is commonly associated with chronic sinusitis that is unresponsive to treatment.<strong> </strong></li><li>Tests of immune function — may diagnose immunoglobulin G deficiency or other immune dysfunction.<strong> </strong></li><li>Testing for cystic fibrosis or ciliary dyskinesia in children with nasal polyps and/or sinonasal colonisation with Pseudomonas spp.</li><li>Initiation of antibiotics.<strong> </strong></li><li>Adenoidectomy (most effective for young children up to 6 years of age).</li><li>Endoscopic sinus surgery — this can remove obstruction and diseased mucosa and provide ventilation and drainage of the paranasal sinuses. </li></ul></li></ul></li></ul><!-- end field 0feb286f-00d9-4086-b6a3-195825956f68 --><!-- end item b28d45fc-c75f-4c0d-a206-c1e67f597ba6 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}